Last reviewed · How we verify
NCT06843096: CEM_CUP_syndr
Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome
trial testing Contrast-Enhanced Mammography (CEM) in Breast Cancer Diagnosis in 350 participants. Enrolling by invitation.
1 March 2025
Quick facts
| Lead sponsor | Graziella di Grezia |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 350 |
| Start date | 1 January 2025 |
| Primary completion | 1 March 2025 |
| Estimated completion | 31 January 2026 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Contrast-Enhanced Mammography (CEM)
Conditions studied
- Breast Cancer Diagnosis — all drugs for Breast Cancer Diagnosis →
- Breast Cancer Prevention — all drugs for Breast Cancer Prevention →
Sponsor
Graziella di Grezia
Who can join
18 and older, female only, with Breast Cancer Diagnosis or Breast Cancer Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the role of Contrast-Enhanced Mammography (CEM) in identifying the primary tumor site in patients presenting with Cancer of Unknown Primary (CUP) syndrome. By integrating functional and anatomical imaging, the study explores CEM's diagnostic value compared to standard imaging modalities in a single-center setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06843096
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Contrast-Enhanced Mammography (CEM)
Trials testing the same drug.
- NCT06993246 — Contrast-enhanced Mammography in Women With a Personal History of Breast Cancer and Dense Breast Tissue: Benefit? · NA · not yet recruiting
Other recruiting trials for Breast Cancer Diagnosis
Currently open trials in the same condition.
- NCT07214883 — UCF MammoChat: Image Repository · recruiting
- NCT06559059 — Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, · recruiting
Other Graziella di Grezia trials
Trials by the same sponsor.
- NCT06843083 — Contrast Enhanced Mammography or Breast Magnetic Resonance: Which Choice for Optimal Diagnostic Performance? · enrolling by invitation
- NCT06846814 — Second-Look Ultrasound Post Contrast-Enhanced Mammography for Additional Lesions Characterization · enrolling by invitation
- NCT06836089 — DWI Breast MRI in Dense Breast: A Clinical Trial to Assess the Efficacy and Diagnostic Accuracy of Diffusion Weighted Im · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06843096 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Graziella di Grezia
- Last refreshed: 24 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06843096.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing